GT
GMAB icon

Greenleaf Trust’s Genmab GMAB Stock Holding History

Greenleaf Trust’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-13,230
Closed -$332K – 837
2024
Q2 		$332K Buy
+13,230
New +$375K ﹤0.01% 588
2023
Q4 		– Sell
-6,018
Closed -$212K – 769
2023
Q3 		$212K Sell
6,018
-322
-5% -$12.3K ﹤0.01% 694
2023
Q2 		$241K Sell
6,340
-10
-0.2% -$399 ﹤0.01% 667
2023
Q1 		$240K Buy
6,350
+290
+5% +$11.1K ﹤0.01% 675
2022
Q4 		$257K Buy
+6,060
New +$250K ﹤0.01% 636
2022
Q3 		– Sell
-6,980
Closed -$227K – 719
2022
Q2 		$227K Sell
6,980
-2,380
-25% -$77.1K ﹤0.01% 641
2022
Q1 		$339K Sell
9,360
-690
-7% -$23.7K ﹤0.01% 553
2021
Q4 		$398K Sell
10,050
-100
-1% -$4.17K ﹤0.01% 500
2021
Q3 		$444K Buy
10,150
+240
+2% +$10.8K 0.01% 432
2021
Q2 		$405K Buy
9,910
+310
+3% +$12K 0.01% 462
2021
Q1 		$315K Buy
9,600
+2,560
+36% +$96.3K ﹤0.01% 532
2020
Q4 		$286K Buy
7,040
+140
+2% +$5.23K ﹤0.01% 473
2020
Q3 		$253K Buy
6,900
+170
+3% +$6.15K ﹤0.01% 452
2020
Q2 		$228K Buy
+6,730
New +$183K ﹤0.01% 471

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Greenleaf Trust's GMAB Position: Q3 2024 in Review

Greenleaf Trust sold out of Genmab (GMAB) in Q3 2024, closing a stake of 13,230 shares — an estimated $332K sold.

Greenleaf Trust first reported a position in GMAB in Q2 2020 and held it in 14 quarters. The position peaked at $444K in Q3 2021. 223 funds tracked by Wall St. Rank hold GMAB as of Q3 2024.

  • Greenleaf Trust reported no remaining Genmab position as of Q3 2024 after selling out during the quarter.
  • Greenleaf Trust sold 13,230 Genmab shares in Q3 2024, an estimated $332K.
  • Greenleaf Trust first reported a position in Genmab in Q2 2020 and held it in 14 quarters.
  • Greenleaf Trust's Genmab position peaked at $444K in Q3 2021.
  • 223 funds tracked by Wall St. Rank held Genmab as of Q3 2024.

Based on Greenleaf Trust's 13F filing for Q3 2024, filed 22 Oct 2024.